| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MAP Kinase Signaling System | 57 | 2026 | 231 | 8.880 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 63 | 2026 | 143 | 8.530 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 53 | 2025 | 83 | 7.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 40 | 2016 | 217 | 4.430 |
Why?
|
| Signal Transduction | 77 | 2026 | 3070 | 4.360 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 30 | 2025 | 46 | 4.250 |
Why?
|
| Adaptor Proteins, Signal Transducing | 18 | 2025 | 432 | 3.190 |
Why?
|
| Mice | 176 | 2025 | 11004 | 2.940 |
Why?
|
| Hepatocytes | 19 | 2025 | 220 | 2.720 |
Why?
|
| Animals | 199 | 2026 | 20967 | 2.540 |
Why?
|
| Apoptosis | 44 | 2025 | 1095 | 2.440 |
Why?
|
| Insulin Resistance | 18 | 2024 | 411 | 2.430 |
Why?
|
| Obesity | 20 | 2026 | 1248 | 2.410 |
Why?
|
| MAP Kinase Kinase Kinases | 14 | 2025 | 82 | 2.250 |
Why?
|
| Adipose Tissue | 11 | 2020 | 297 | 2.210 |
Why?
|
| Mice, Inbred C57BL | 78 | 2025 | 3450 | 2.200 |
Why?
|
| Liver | 20 | 2025 | 868 | 2.140 |
Why?
|
| Mice, Knockout | 76 | 2025 | 2140 | 2.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 23 | 2021 | 617 | 1.950 |
Why?
|
| Phosphorylation | 57 | 2025 | 948 | 1.930 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 33 | 2016 | 152 | 1.830 |
Why?
|
| Fibroblast Growth Factors | 5 | 2022 | 74 | 1.770 |
Why?
|
| MAP Kinase Kinase 4 | 17 | 2022 | 46 | 1.730 |
Why?
|
| Cell Transformation, Neoplastic | 12 | 2023 | 207 | 1.680 |
Why?
|
| Stress, Physiological | 5 | 2017 | 196 | 1.570 |
Why?
|
| Diet, High-Fat | 14 | 2025 | 176 | 1.550 |
Why?
|
| Enzyme Activation | 41 | 2018 | 386 | 1.430 |
Why?
|
| Gene Expression Regulation | 22 | 2020 | 1622 | 1.420 |
Why?
|
| PPAR alpha | 4 | 2022 | 34 | 1.350 |
Why?
|
| Journal Impact Factor | 7 | 2017 | 26 | 1.260 |
Why?
|
| Neurons | 16 | 2025 | 934 | 1.250 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 8 | 2010 | 106 | 1.190 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 15 | 2011 | 58 | 1.180 |
Why?
|
| Cells, Cultured | 41 | 2025 | 2177 | 1.160 |
Why?
|
| Mammary Glands, Animal | 4 | 2018 | 79 | 1.040 |
Why?
|
| Epithelial Cells | 8 | 2021 | 401 | 0.990 |
Why?
|
| Interleukin-6 | 12 | 2020 | 325 | 0.980 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2010 | 329 | 0.940 |
Why?
|
| Autocrine Communication | 3 | 2020 | 30 | 0.940 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 8 | 2019 | 12 | 0.940 |
Why?
|
| Cell Survival | 8 | 2018 | 582 | 0.910 |
Why?
|
| Adipocytes | 8 | 2021 | 269 | 0.890 |
Why?
|
| Liver Neoplasms | 4 | 2017 | 306 | 0.870 |
Why?
|
| Fatty Liver | 6 | 2025 | 109 | 0.860 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2017 | 181 | 0.840 |
Why?
|
| MAP Kinase Kinase 3 | 23 | 2014 | 27 | 0.830 |
Why?
|
| Apoptosis Regulatory Proteins | 5 | 2017 | 151 | 0.820 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 12 | 2018 | 343 | 0.810 |
Why?
|
| Autophagy | 3 | 2018 | 231 | 0.800 |
Why?
|
| Carcinogenesis | 5 | 2018 | 131 | 0.790 |
Why?
|
| Myeloid Cells | 3 | 2020 | 94 | 0.790 |
Why?
|
| Anoikis | 3 | 2018 | 7 | 0.780 |
Why?
|
| Oxidative Stress | 6 | 2025 | 304 | 0.770 |
Why?
|
| Inflammation | 12 | 2023 | 1163 | 0.770 |
Why?
|
| Hepatitis | 2 | 2016 | 58 | 0.760 |
Why?
|
| Membrane Proteins | 8 | 2019 | 909 | 0.740 |
Why?
|
| Fibroblasts | 14 | 2011 | 404 | 0.730 |
Why?
|
| Publishing | 3 | 2018 | 93 | 0.730 |
Why?
|
| Proto-Oncogene Proteins c-jun | 7 | 2007 | 28 | 0.730 |
Why?
|
| Macrophages | 10 | 2021 | 1053 | 0.720 |
Why?
|
| Mice, Transgenic | 24 | 2020 | 1297 | 0.700 |
Why?
|
| Energy Metabolism | 7 | 2026 | 384 | 0.680 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 142 | 0.680 |
Why?
|
| Cell Proliferation | 18 | 2025 | 1002 | 0.680 |
Why?
|
| Mitochondrial Proteins | 3 | 2019 | 106 | 0.680 |
Why?
|
| Male | 70 | 2025 | 30322 | 0.670 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 1213 | 0.670 |
Why?
|
| Prostatic Neoplasms | 6 | 2016 | 421 | 0.660 |
Why?
|
| MAP Kinase Kinase 7 | 10 | 2021 | 14 | 0.660 |
Why?
|
| Carrier Proteins | 7 | 2022 | 709 | 0.650 |
Why?
|
| Tumor Suppressor Protein p53 | 7 | 2019 | 310 | 0.650 |
Why?
|
| Periodicals as Topic | 6 | 2017 | 175 | 0.630 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2019 | 268 | 0.620 |
Why?
|
| Ischemia | 3 | 2019 | 196 | 0.610 |
Why?
|
| Transcription Factor AP-1 | 6 | 2018 | 41 | 0.610 |
Why?
|
| Antigens, Neoplasm | 2 | 2016 | 136 | 0.590 |
Why?
|
| Humans | 83 | 2026 | 64283 | 0.590 |
Why?
|
| Cytokines | 10 | 2021 | 945 | 0.590 |
Why?
|
| Insulin | 9 | 2017 | 686 | 0.580 |
Why?
|
| Genomic Instability | 2 | 2018 | 55 | 0.580 |
Why?
|
| Transcription Factors | 13 | 2019 | 1541 | 0.580 |
Why?
|
| src-Family Kinases | 2 | 2019 | 64 | 0.570 |
Why?
|
| Alternative Splicing | 2 | 2016 | 130 | 0.570 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2015 | 85 | 0.560 |
Why?
|
| ras Proteins | 4 | 2018 | 77 | 0.550 |
Why?
|
| Models, Biological | 11 | 2016 | 1187 | 0.550 |
Why?
|
| Thermogenesis | 3 | 2025 | 122 | 0.540 |
Why?
|
| Amino Acids | 1 | 2018 | 148 | 0.530 |
Why?
|
| Caspase 8 | 4 | 2025 | 65 | 0.530 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2017 | 62 | 0.520 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2015 | 210 | 0.520 |
Why?
|
| Editorial Policies | 5 | 2018 | 55 | 0.510 |
Why?
|
| Cell Differentiation | 12 | 2014 | 1366 | 0.510 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2016 | 65 | 0.490 |
Why?
|
| DNA-Binding Proteins | 8 | 2016 | 1197 | 0.490 |
Why?
|
| Lung Neoplasms | 4 | 2025 | 696 | 0.480 |
Why?
|
| Molecular Mimicry | 1 | 2016 | 31 | 0.480 |
Why?
|
| RNA-Binding Proteins | 3 | 2016 | 446 | 0.480 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2025 | 534 | 0.480 |
Why?
|
| Cell Line, Tumor | 16 | 2023 | 1496 | 0.480 |
Why?
|
| Disease Models, Animal | 17 | 2025 | 2238 | 0.480 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 104 | 0.470 |
Why?
|
| Leukemia | 1 | 2016 | 60 | 0.470 |
Why?
|
| Research | 1 | 2017 | 196 | 0.470 |
Why?
|
| Femoral Artery | 1 | 2016 | 99 | 0.470 |
Why?
|
| Nerve Tissue Proteins | 4 | 2008 | 429 | 0.460 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 58 | 0.460 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 3 | 2014 | 10 | 0.460 |
Why?
|
| Adenocarcinoma | 3 | 2016 | 356 | 0.460 |
Why?
|
| Homeostasis | 7 | 2025 | 370 | 0.450 |
Why?
|
| Thyroid Hormones | 3 | 2025 | 80 | 0.450 |
Why?
|
| Protein-Tyrosine Kinases | 8 | 2007 | 128 | 0.440 |
Why?
|
| Insulin Receptor Substrate Proteins | 4 | 2009 | 55 | 0.440 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 63 | 0.430 |
Why?
|
| Female | 36 | 2025 | 33382 | 0.420 |
Why?
|
| Iodide Peroxidase | 1 | 2013 | 23 | 0.410 |
Why?
|
| Cardiomegaly | 4 | 2022 | 37 | 0.410 |
Why?
|
| Hypothalamus | 3 | 2026 | 133 | 0.410 |
Why?
|
| Cell Line | 18 | 2018 | 2057 | 0.410 |
Why?
|
| Neoplasms | 6 | 2016 | 1393 | 0.400 |
Why?
|
| Melanoma | 1 | 2017 | 331 | 0.400 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2018 | 90 | 0.400 |
Why?
|
| MAP Kinase Kinase 6 | 11 | 2014 | 12 | 0.390 |
Why?
|
| Protein Kinase Inhibitors | 8 | 2021 | 189 | 0.390 |
Why?
|
| Glucose | 7 | 2024 | 471 | 0.380 |
Why?
|
| Reactive Oxygen Species | 5 | 2019 | 237 | 0.380 |
Why?
|
| Chemical and Drug Induced Liver Injury | 3 | 2019 | 53 | 0.360 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 63 | 0.350 |
Why?
|
| Bcl-2-Like Protein 11 | 4 | 2019 | 20 | 0.350 |
Why?
|
| Protein Kinases | 5 | 2010 | 153 | 0.350 |
Why?
|
| Cellular Senescence | 3 | 2017 | 112 | 0.340 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 5 | 2019 | 46 | 0.340 |
Why?
|
| Cell Death | 12 | 2021 | 286 | 0.340 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 131 | 0.340 |
Why?
|
| Liver Failure, Acute | 3 | 2019 | 26 | 0.340 |
Why?
|
| T-Lymphocytes | 6 | 2010 | 1019 | 0.340 |
Why?
|
| Glycogen Synthase Kinase 3 | 4 | 2016 | 46 | 0.340 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2015 | 644 | 0.330 |
Why?
|
| Mutation | 9 | 2021 | 2633 | 0.330 |
Why?
|
| Cell Movement | 6 | 2021 | 466 | 0.330 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 667 | 0.330 |
Why?
|
| Precancerous Conditions | 1 | 2011 | 71 | 0.330 |
Why?
|
| Trans-Activators | 4 | 2004 | 312 | 0.320 |
Why?
|
| Interferon-gamma | 8 | 2018 | 576 | 0.320 |
Why?
|
| Gene Expression Profiling | 8 | 2018 | 783 | 0.320 |
Why?
|
| Pituitary Gland | 1 | 2010 | 51 | 0.320 |
Why?
|
| Transcription, Genetic | 11 | 2018 | 884 | 0.320 |
Why?
|
| Dietary Fats | 5 | 2011 | 175 | 0.310 |
Why?
|
| Thyroid Gland | 1 | 2010 | 82 | 0.310 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2010 | 88 | 0.310 |
Why?
|
| Lipid Metabolism | 4 | 2026 | 223 | 0.300 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2015 | 91 | 0.300 |
Why?
|
| DNA Fragmentation | 2 | 2006 | 34 | 0.300 |
Why?
|
| Morphogenesis | 4 | 2016 | 114 | 0.300 |
Why?
|
| Protein Isoforms | 7 | 2009 | 199 | 0.300 |
Why?
|
| Glucose Intolerance | 1 | 2009 | 90 | 0.290 |
Why?
|
| Cholangiocarcinoma | 2 | 2020 | 34 | 0.290 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 157 | 0.290 |
Why?
|
| Phosphotyrosine | 2 | 2019 | 24 | 0.290 |
Why?
|
| Cell Lineage | 1 | 2010 | 273 | 0.290 |
Why?
|
| Feedback, Physiological | 3 | 2020 | 59 | 0.280 |
Why?
|
| Protein Binding | 11 | 2025 | 1619 | 0.280 |
Why?
|
| Gene Deletion | 5 | 2020 | 312 | 0.280 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2012 | 446 | 0.280 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2012 | 567 | 0.280 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2019 | 204 | 0.270 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2019 | 679 | 0.270 |
Why?
|
| N-Methylaspartate | 1 | 2007 | 16 | 0.270 |
Why?
|
| Muscle, Skeletal | 3 | 2019 | 747 | 0.270 |
Why?
|
| Motor Neurons | 3 | 2006 | 215 | 0.270 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2007 | 56 | 0.260 |
Why?
|
| Lipopolysaccharides | 7 | 2021 | 625 | 0.260 |
Why?
|
| Mice, Mutant Strains | 7 | 2021 | 302 | 0.260 |
Why?
|
| Mice, Nude | 5 | 2013 | 281 | 0.260 |
Why?
|
| Reperfusion Injury | 3 | 2021 | 56 | 0.260 |
Why?
|
| Models, Molecular | 4 | 2025 | 1160 | 0.250 |
Why?
|
| Oncogenes | 1 | 2006 | 70 | 0.250 |
Why?
|
| Blood Glucose | 3 | 2016 | 487 | 0.240 |
Why?
|
| Immunoblotting | 8 | 2018 | 206 | 0.240 |
Why?
|
| Liver Cirrhosis | 3 | 2025 | 180 | 0.240 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2025 | 5 | 0.230 |
Why?
|
| Liver Regeneration | 3 | 2017 | 20 | 0.230 |
Why?
|
| Nuclear Proteins | 3 | 2005 | 785 | 0.230 |
Why?
|
| Coiled Bodies | 1 | 2005 | 4 | 0.230 |
Why?
|
| Ultraviolet Rays | 4 | 2009 | 141 | 0.230 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2008 | 201 | 0.230 |
Why?
|
| Base Sequence | 10 | 2016 | 1335 | 0.230 |
Why?
|
| Lung | 4 | 2020 | 964 | 0.230 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2025 | 91 | 0.230 |
Why?
|
| Isoenzymes | 6 | 2014 | 141 | 0.230 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2024 | 3 | 0.220 |
Why?
|
| DNA Damage | 3 | 2017 | 289 | 0.220 |
Why?
|
| Integrin beta1 | 2 | 2016 | 32 | 0.220 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2025 | 14 | 0.220 |
Why?
|
| Immunohistochemistry | 9 | 2021 | 901 | 0.220 |
Why?
|
| Cholestasis | 1 | 2025 | 66 | 0.220 |
Why?
|
| Transforming Growth Factor beta | 2 | 2011 | 174 | 0.220 |
Why?
|
| Histones | 2 | 2017 | 486 | 0.220 |
Why?
|
| Bile Acids and Salts | 2 | 2025 | 24 | 0.220 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 47 | 0.220 |
Why?
|
| Neovascularization, Pathologic | 1 | 2025 | 141 | 0.210 |
Why?
|
| Rats | 11 | 2021 | 2005 | 0.210 |
Why?
|
| Gene Expression | 5 | 2011 | 851 | 0.210 |
Why?
|
| Telencephalon | 1 | 2003 | 10 | 0.200 |
Why?
|
| Mitochondria | 6 | 2017 | 384 | 0.200 |
Why?
|
| Cell Division | 5 | 2010 | 455 | 0.200 |
Why?
|
| Recombinant Proteins | 6 | 2018 | 705 | 0.200 |
Why?
|
| Coloboma | 1 | 2003 | 2 | 0.200 |
Why?
|
| Protein Multimerization | 1 | 2024 | 182 | 0.200 |
Why?
|
| Hyperglycemia | 3 | 2024 | 105 | 0.200 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2021 | 81 | 0.200 |
Why?
|
| NF-kappa B | 5 | 2006 | 471 | 0.200 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2022 | 8 | 0.190 |
Why?
|
| Muscle Cells | 2 | 2020 | 28 | 0.190 |
Why?
|
| Immunologic Memory | 2 | 2019 | 290 | 0.190 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 57 | 0.190 |
Why?
|
| fas Receptor | 2 | 2019 | 57 | 0.190 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2018 | 248 | 0.190 |
Why?
|
| Insulin-Secreting Cells | 3 | 2015 | 189 | 0.190 |
Why?
|
| Vesicular Transport Proteins | 1 | 2003 | 115 | 0.190 |
Why?
|
| Societies, Scientific | 3 | 2016 | 36 | 0.190 |
Why?
|
| Islets of Langerhans | 2 | 2015 | 280 | 0.190 |
Why?
|
| Lymphocytes | 2 | 2016 | 203 | 0.180 |
Why?
|
| Phosphoproteins | 4 | 2014 | 221 | 0.180 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2021 | 6 | 0.180 |
Why?
|
| Chromatin | 1 | 2006 | 616 | 0.180 |
Why?
|
| Cyclic GMP-Dependent Protein Kinase Type I | 1 | 2021 | 1 | 0.180 |
Why?
|
| TRPP Cation Channels | 1 | 2021 | 25 | 0.180 |
Why?
|
| Macrophages, Peritoneal | 4 | 2013 | 78 | 0.180 |
Why?
|
| Binding Sites | 7 | 2025 | 914 | 0.180 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 271 | 0.180 |
Why?
|
| Cell Nucleus | 5 | 2018 | 634 | 0.180 |
Why?
|
| bcl-2-Associated X Protein | 4 | 2007 | 48 | 0.180 |
Why?
|
| Axons | 3 | 2015 | 126 | 0.170 |
Why?
|
| Skin | 1 | 2004 | 386 | 0.170 |
Why?
|
| Brain | 6 | 2015 | 1581 | 0.170 |
Why?
|
| Time Factors | 11 | 2015 | 3725 | 0.170 |
Why?
|
| Bile Duct Diseases | 1 | 2021 | 10 | 0.170 |
Why?
|
| Protein Domains | 2 | 2022 | 154 | 0.170 |
Why?
|
| Cysts | 1 | 2021 | 43 | 0.170 |
Why?
|
| Endocrine System | 1 | 2020 | 17 | 0.170 |
Why?
|
| CLOCK Proteins | 1 | 2020 | 47 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 6 | 2019 | 891 | 0.170 |
Why?
|
| Adiponectin | 1 | 2020 | 37 | 0.170 |
Why?
|
| Point Mutation | 3 | 2018 | 165 | 0.170 |
Why?
|
| Hippocampus | 6 | 2018 | 278 | 0.170 |
Why?
|
| rho-Associated Kinases | 3 | 2024 | 18 | 0.160 |
Why?
|
| RNA, Messenger | 8 | 2019 | 1552 | 0.160 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2020 | 60 | 0.160 |
Why?
|
| Amino Acid Sequence | 7 | 2010 | 1597 | 0.160 |
Why?
|
| Phenotype | 3 | 2018 | 1223 | 0.160 |
Why?
|
| Molecular Sequence Data | 8 | 2016 | 1999 | 0.160 |
Why?
|
| ADAM17 Protein | 1 | 2020 | 8 | 0.160 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 3 | 2011 | 59 | 0.160 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 165 | 0.160 |
Why?
|
| ADAM10 Protein | 1 | 2020 | 11 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2021 | 625 | 0.160 |
Why?
|
| Mitochondrial Membranes | 1 | 2019 | 8 | 0.160 |
Why?
|
| Microscopy, Fluorescence | 3 | 2014 | 402 | 0.160 |
Why?
|
| Phosphotransferases | 1 | 1999 | 23 | 0.160 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2019 | 16 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 4 | 2010 | 674 | 0.150 |
Why?
|
| Hindlimb | 1 | 2019 | 45 | 0.150 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 572 | 0.150 |
Why?
|
| Unfolded Protein Response | 2 | 2018 | 58 | 0.150 |
Why?
|
| Embryo, Mammalian | 3 | 2010 | 156 | 0.150 |
Why?
|
| Organ Specificity | 2 | 2010 | 196 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2011 | 56 | 0.150 |
Why?
|
| Species Specificity | 1 | 2020 | 334 | 0.150 |
Why?
|
| Receptor, IGF Type 1 | 3 | 2016 | 30 | 0.150 |
Why?
|
| beta Catenin | 3 | 2008 | 99 | 0.150 |
Why?
|
| Heart Failure | 2 | 2021 | 926 | 0.150 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 142 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 11 | 0.150 |
Why?
|
| Neutrophils | 2 | 2020 | 378 | 0.150 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2018 | 10 | 0.150 |
Why?
|
| Bone Marrow | 2 | 2014 | 175 | 0.150 |
Why?
|
| Gliotoxin | 1 | 2018 | 5 | 0.150 |
Why?
|
| Carbon Monoxide | 3 | 2003 | 63 | 0.150 |
Why?
|
| Mesoderm | 2 | 2010 | 85 | 0.150 |
Why?
|
| Naphthyridines | 1 | 2018 | 6 | 0.150 |
Why?
|
| HEK293 Cells | 5 | 2021 | 627 | 0.140 |
Why?
|
| Osteoblasts | 2 | 2017 | 201 | 0.140 |
Why?
|
| Kidney | 4 | 2021 | 455 | 0.140 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 42 | 0.140 |
Why?
|
| Crystallography, X-Ray | 3 | 2025 | 436 | 0.140 |
Why?
|
| Smad Proteins | 1 | 2018 | 23 | 0.140 |
Why?
|
| Myostatin | 1 | 2018 | 16 | 0.140 |
Why?
|
| Ventricular Remodeling | 3 | 2022 | 89 | 0.140 |
Why?
|
| Spatial Memory | 1 | 2018 | 8 | 0.140 |
Why?
|
| Cell Biology | 1 | 2018 | 22 | 0.140 |
Why?
|
| Smad2 Protein | 1 | 2018 | 8 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 2023 | 13 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 209 | 0.140 |
Why?
|
| Matrix Metalloproteinases | 1 | 2018 | 16 | 0.140 |
Why?
|
| Interleukin-1 | 4 | 2008 | 156 | 0.140 |
Why?
|
| Cathepsins | 1 | 2018 | 34 | 0.140 |
Why?
|
| Exome | 1 | 2018 | 77 | 0.140 |
Why?
|
| Virulence Factors | 1 | 2018 | 85 | 0.140 |
Why?
|
| DNA Mutational Analysis | 3 | 2009 | 197 | 0.140 |
Why?
|
| Molecular Biology | 1 | 2018 | 67 | 0.140 |
Why?
|
| Immunophenotyping | 2 | 2021 | 197 | 0.140 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2020 | 158 | 0.140 |
Why?
|
| Metabolome | 1 | 2017 | 34 | 0.140 |
Why?
|
| Pyridines | 5 | 2021 | 114 | 0.140 |
Why?
|
| Palmitates | 1 | 2017 | 21 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 125 | 0.140 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2017 | 20 | 0.130 |
Why?
|
| Lactation | 1 | 2018 | 70 | 0.130 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 72 | 0.130 |
Why?
|
| Heat-Shock Proteins | 1 | 2018 | 68 | 0.130 |
Why?
|
| Myocardium | 4 | 2007 | 288 | 0.130 |
Why?
|
| Muscles | 1 | 2018 | 179 | 0.130 |
Why?
|
| Membrane Microdomains | 1 | 2017 | 50 | 0.130 |
Why?
|
| Lymphocyte Activation | 4 | 2011 | 761 | 0.130 |
Why?
|
| Kupffer Cells | 1 | 2017 | 43 | 0.130 |
Why?
|
| Myocytes, Cardiac | 3 | 2018 | 120 | 0.130 |
Why?
|
| Caloric Restriction | 1 | 2017 | 19 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 2 | 2015 | 6 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 259 | 0.130 |
Why?
|
| Bile Duct Neoplasms | 1 | 2017 | 58 | 0.130 |
Why?
|
| In Vitro Techniques | 5 | 2006 | 490 | 0.130 |
Why?
|
| In Situ Nick-End Labeling | 8 | 2011 | 49 | 0.130 |
Why?
|
| Acetaminophen | 3 | 2019 | 57 | 0.130 |
Why?
|
| Membrane Glycoproteins | 2 | 2014 | 671 | 0.130 |
Why?
|
| Down-Regulation | 4 | 2013 | 320 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 199 | 0.130 |
Why?
|
| Epigenomics | 1 | 2017 | 62 | 0.130 |
Why?
|
| Lymphocytic Choriomeningitis | 2 | 2010 | 53 | 0.130 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 153 | 0.120 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 31 | 0.120 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2016 | 18 | 0.120 |
Why?
|
| Osteogenesis | 1 | 2017 | 149 | 0.120 |
Why?
|
| Peroxisomal Bifunctional Enzyme | 1 | 2016 | 1 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 195 | 0.120 |
Why?
|
| Blotting, Western | 8 | 2010 | 614 | 0.120 |
Why?
|
| Agouti-Related Protein | 1 | 2016 | 6 | 0.120 |
Why?
|
| Resistin | 1 | 2016 | 7 | 0.120 |
Why?
|
| Beclin-1 | 2 | 2018 | 22 | 0.120 |
Why?
|
| Protein Transport | 4 | 2018 | 405 | 0.120 |
Why?
|
| Hyperphagia | 1 | 2016 | 18 | 0.120 |
Why?
|
| Integrins | 1 | 2016 | 109 | 0.120 |
Why?
|
| Serine | 4 | 2010 | 91 | 0.120 |
Why?
|
| Peer Review, Research | 1 | 2016 | 47 | 0.120 |
Why?
|
| Genes, Reporter | 4 | 2008 | 260 | 0.120 |
Why?
|
| Microtubule-Associated Proteins | 4 | 2014 | 114 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 4 | 2011 | 519 | 0.120 |
Why?
|
| Leptin | 1 | 2016 | 87 | 0.120 |
Why?
|
| Radiation Tolerance | 2 | 2013 | 56 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 132 | 0.120 |
Why?
|
| Somatostatin-Secreting Cells | 1 | 2015 | 8 | 0.120 |
Why?
|
| Macrophage Activation | 2 | 2012 | 119 | 0.120 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 88 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2016 | 117 | 0.110 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2015 | 26 | 0.110 |
Why?
|
| Panniculitis | 1 | 2015 | 4 | 0.110 |
Why?
|
| Aging | 1 | 2021 | 754 | 0.110 |
Why?
|
| Estrogen Receptor beta | 1 | 2015 | 24 | 0.110 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2023 | 85 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2017 | 216 | 0.110 |
Why?
|
| Odontogenesis | 1 | 2014 | 2 | 0.110 |
Why?
|
| Ameloblasts | 1 | 2014 | 3 | 0.110 |
Why?
|
| Presynaptic Terminals | 1 | 2015 | 38 | 0.110 |
Why?
|
| Incisor | 1 | 2014 | 7 | 0.110 |
Why?
|
| Acetyl Coenzyme A | 1 | 2015 | 24 | 0.110 |
Why?
|
| Dental Enamel | 1 | 2014 | 13 | 0.110 |
Why?
|
| cdc42 GTP-Binding Protein | 2 | 2011 | 22 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 544 | 0.110 |
Why?
|
| Fetus | 1 | 2015 | 100 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 709 | 0.110 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 2 | 2017 | 24 | 0.110 |
Why?
|
| Intestines | 2 | 2007 | 169 | 0.110 |
Why?
|
| Proteins | 4 | 2011 | 760 | 0.110 |
Why?
|
| 3T3 Cells | 3 | 2012 | 112 | 0.110 |
Why?
|
| Protein Conformation | 4 | 2025 | 785 | 0.110 |
Why?
|
| Glutamic Acid | 1 | 2015 | 101 | 0.110 |
Why?
|
| Disease Progression | 5 | 2025 | 1176 | 0.110 |
Why?
|
| Axonal Transport | 1 | 2014 | 32 | 0.110 |
Why?
|
| Computational Biology | 1 | 2016 | 357 | 0.110 |
Why?
|
| Flow Cytometry | 5 | 2018 | 668 | 0.110 |
Why?
|
| Transcriptome | 1 | 2017 | 396 | 0.110 |
Why?
|
| Neoplasms, Experimental | 2 | 2005 | 78 | 0.110 |
Why?
|
| Gene Targeting | 2 | 2005 | 77 | 0.110 |
Why?
|
| Steroids | 1 | 2014 | 55 | 0.100 |
Why?
|
| Cell Cycle | 3 | 2006 | 396 | 0.100 |
Why?
|
| Cholesterol | 2 | 2005 | 260 | 0.100 |
Why?
|
| COS Cells | 3 | 2014 | 175 | 0.100 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2013 | 30 | 0.100 |
Why?
|
| Th1 Cells | 2 | 2005 | 173 | 0.100 |
Why?
|
| Enzyme Inhibitors | 6 | 2006 | 373 | 0.100 |
Why?
|
| Diet | 2 | 2010 | 533 | 0.100 |
Why?
|
| Borrelia burgdorferi | 2 | 2007 | 92 | 0.100 |
Why?
|
| Pyrazoles | 2 | 2021 | 87 | 0.100 |
Why?
|
| Interleukin-10 | 2 | 2006 | 161 | 0.100 |
Why?
|
| Hepatic Stellate Cells | 1 | 2013 | 24 | 0.100 |
Why?
|
| Adherens Junctions | 1 | 2013 | 11 | 0.100 |
Why?
|
| Cell Separation | 2 | 2011 | 146 | 0.100 |
Why?
|
| Coenzyme A Ligases | 1 | 2013 | 13 | 0.100 |
Why?
|
| Kinetics | 2 | 2007 | 766 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2010 | 43 | 0.100 |
Why?
|
| Caspases | 3 | 2003 | 176 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2010 | 46 | 0.100 |
Why?
|
| Peptide Elongation Factor 2 | 1 | 2012 | 5 | 0.100 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2012 | 6 | 0.100 |
Why?
|
| Hypothalamic Hormones | 1 | 2012 | 4 | 0.100 |
Why?
|
| Pituitary Hormones | 1 | 2012 | 7 | 0.100 |
Why?
|
| Pancreas | 2 | 2014 | 154 | 0.100 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2012 | 12 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 1 | 2013 | 56 | 0.100 |
Why?
|
| Glucose Clamp Technique | 1 | 2012 | 57 | 0.100 |
Why?
|
| Eating | 2 | 2012 | 139 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 2 | 2011 | 460 | 0.100 |
Why?
|
| DNA Primers | 3 | 2009 | 295 | 0.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2014 | 115 | 0.100 |
Why?
|
| Melanins | 1 | 2012 | 25 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2011 | 110 | 0.100 |
Why?
|
| Dendrites | 2 | 2010 | 61 | 0.100 |
Why?
|
| Phospholipids | 1 | 2013 | 82 | 0.100 |
Why?
|
| Ganglia, Spinal | 2 | 2010 | 30 | 0.100 |
Why?
|
| Lymphocytic choriomeningitis virus | 3 | 2019 | 89 | 0.090 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2012 | 31 | 0.090 |
Why?
|
| Histological Techniques | 1 | 2012 | 18 | 0.090 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2012 | 4 | 0.090 |
Why?
|
| Caspase 3 | 4 | 2013 | 108 | 0.090 |
Why?
|
| Thymus Gland | 3 | 2008 | 237 | 0.090 |
Why?
|
| Adiposity | 1 | 2012 | 83 | 0.090 |
Why?
|
| Triiodothyronine | 2 | 2025 | 30 | 0.090 |
Why?
|
| Neuropilin-2 | 1 | 2012 | 40 | 0.090 |
Why?
|
| Cerebral Cortex | 3 | 2015 | 267 | 0.090 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 36 | 0.090 |
Why?
|
| Hand Deformities, Congenital | 1 | 2011 | 4 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2011 | 3 | 0.090 |
Why?
|
| Autoimmunity | 2 | 2011 | 240 | 0.090 |
Why?
|
| Dwarfism | 1 | 2011 | 15 | 0.090 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2011 | 10 | 0.090 |
Why?
|
| Plaque, Amyloid | 1 | 2011 | 41 | 0.090 |
Why?
|
| Blood Pressure | 3 | 2022 | 517 | 0.090 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2011 | 15 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 685 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 11 | 1 | 2011 | 3 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2009 | 174 | 0.090 |
Why?
|
| Bone Development | 1 | 2011 | 32 | 0.090 |
Why?
|
| RNA | 1 | 2015 | 429 | 0.090 |
Why?
|
| Tyrosine | 1 | 2011 | 94 | 0.090 |
Why?
|
| Electrophoretic Mobility Shift Assay | 3 | 2008 | 65 | 0.090 |
Why?
|
| Protein Modification, Translational | 1 | 2011 | 6 | 0.090 |
Why?
|
| Contact Inhibition | 1 | 2011 | 3 | 0.090 |
Why?
|
| Microtubules | 2 | 2010 | 210 | 0.090 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2011 | 17 | 0.090 |
Why?
|
| Th17 Cells | 1 | 2011 | 62 | 0.090 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2011 | 17 | 0.090 |
Why?
|
| Activating Transcription Factor 2 | 3 | 2011 | 13 | 0.090 |
Why?
|
| Wnt Proteins | 2 | 2008 | 100 | 0.090 |
Why?
|
| Immunity, Innate | 4 | 2018 | 803 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 28 | 0.090 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2010 | 5 | 0.090 |
Why?
|
| Natural Killer T-Cells | 1 | 2011 | 29 | 0.090 |
Why?
|
| Intestinal Neoplasms | 2 | 2008 | 14 | 0.080 |
Why?
|
| Interleukin-2 | 4 | 2004 | 167 | 0.080 |
Why?
|
| Protein Kinase C | 2 | 2010 | 103 | 0.080 |
Why?
|
| Association Learning | 1 | 2010 | 8 | 0.080 |
Why?
|
| Pressure | 1 | 2011 | 78 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2016 | 235 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 350 | 0.080 |
Why?
|
| Interleukin-17 | 1 | 2011 | 101 | 0.080 |
Why?
|
| Plasmids | 3 | 2014 | 293 | 0.080 |
Why?
|
| Cadherins | 1 | 2011 | 82 | 0.080 |
Why?
|
| Amino Acid Substitution | 2 | 2009 | 239 | 0.080 |
Why?
|
| Neurites | 1 | 2010 | 23 | 0.080 |
Why?
|
| Adipose Tissue, Brown | 2 | 2025 | 119 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 104 | 0.080 |
Why?
|
| Adipokines | 1 | 2010 | 32 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2007 | 645 | 0.080 |
Why?
|
| cdc25 Phosphatases | 1 | 2010 | 7 | 0.080 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2010 | 5 | 0.080 |
Why?
|
| Platelet Aggregation | 1 | 2010 | 25 | 0.080 |
Why?
|
| G2 Phase | 1 | 2010 | 24 | 0.080 |
Why?
|
| Hydrocolpos | 1 | 2010 | 1 | 0.080 |
Why?
|
| Limb Deformities, Congenital | 1 | 2010 | 3 | 0.080 |
Why?
|
| Cyclic AMP | 1 | 2010 | 145 | 0.080 |
Why?
|
| Nerve Regeneration | 1 | 2010 | 38 | 0.080 |
Why?
|
| Poly I-C | 1 | 2010 | 76 | 0.080 |
Why?
|
| Pyrroles | 2 | 2021 | 52 | 0.080 |
Why?
|
| Teratoma | 1 | 2010 | 13 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 2 | 2016 | 279 | 0.080 |
Why?
|
| Organogenesis | 1 | 2010 | 39 | 0.080 |
Why?
|
| Myocardial Contraction | 2 | 2007 | 89 | 0.080 |
Why?
|
| Vagina | 1 | 2010 | 87 | 0.080 |
Why?
|
| Drosophila | 2 | 2003 | 439 | 0.080 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2008 | 8 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2010 | 587 | 0.070 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 14 | 0.070 |
Why?
|
| Blood Platelets | 1 | 2010 | 104 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2008 | 110 | 0.070 |
Why?
|
| Pyramidal Cells | 1 | 2008 | 27 | 0.070 |
Why?
|
| Transfection | 5 | 2014 | 696 | 0.070 |
Why?
|
| Conserved Sequence | 3 | 2007 | 173 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 72 | 0.070 |
Why?
|
| Mitosis | 1 | 2010 | 218 | 0.070 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2008 | 81 | 0.070 |
Why?
|
| Proteome | 1 | 2009 | 155 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2007 | 59 | 0.070 |
Why?
|
| Radiation Injuries | 1 | 2008 | 66 | 0.070 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 433 | 0.070 |
Why?
|
| Peripheral Nervous System | 1 | 2007 | 11 | 0.070 |
Why?
|
| Alzheimer Disease | 1 | 2015 | 749 | 0.070 |
Why?
|
| Ehrlichiosis | 1 | 2007 | 6 | 0.070 |
Why?
|
| Epithelium | 1 | 2008 | 96 | 0.070 |
Why?
|
| Anaplasma phagocytophilum | 1 | 2007 | 9 | 0.070 |
Why?
|
| Retinoblastoma Protein | 1 | 2007 | 37 | 0.070 |
Why?
|
| Bromodeoxyuridine | 2 | 2004 | 44 | 0.070 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2007 | 22 | 0.070 |
Why?
|
| Nephritis | 1 | 2007 | 11 | 0.070 |
Why?
|
| Thrombosis | 1 | 2010 | 198 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 2 | 2005 | 175 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2007 | 51 | 0.070 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2007 | 28 | 0.070 |
Why?
|
| Ureteral Obstruction | 1 | 2007 | 28 | 0.070 |
Why?
|
| Pancreatitis | 1 | 2008 | 98 | 0.070 |
Why?
|
| Hypoxia | 2 | 2005 | 116 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 203 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2007 | 72 | 0.060 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2006 | 13 | 0.060 |
Why?
|
| Axis, Cervical Vertebra | 1 | 2006 | 4 | 0.060 |
Why?
|
| Chronic Disease | 3 | 2017 | 756 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2007 | 97 | 0.060 |
Why?
|
| Dendritic Cells | 1 | 2010 | 529 | 0.060 |
Why?
|
| Cerebellum | 1 | 2007 | 95 | 0.060 |
Why?
|
| Melanoma, Experimental | 1 | 2007 | 44 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2006 | 34 | 0.060 |
Why?
|
| Xenopus | 1 | 2006 | 55 | 0.060 |
Why?
|
| Microbiology | 2 | 2016 | 6 | 0.060 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2006 | 36 | 0.060 |
Why?
|
| Germ-Line Mutation | 1 | 2006 | 45 | 0.060 |
Why?
|
| RNA Interference | 2 | 2012 | 621 | 0.060 |
Why?
|
| Immunity | 2 | 2004 | 107 | 0.060 |
Why?
|
| Arthritis, Experimental | 1 | 2006 | 29 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 2003 | 166 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2014 | 114 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2010 | 479 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2006 | 179 | 0.060 |
Why?
|
| Catalytic Domain | 2 | 2008 | 205 | 0.060 |
Why?
|
| Anthracenes | 3 | 2016 | 12 | 0.060 |
Why?
|
| Cytochrome c Group | 2 | 2003 | 25 | 0.060 |
Why?
|
| Antimycin A | 1 | 2005 | 3 | 0.060 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2005 | 6 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2006 | 72 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2006 | 340 | 0.060 |
Why?
|
| Pyrimidines | 1 | 2006 | 146 | 0.060 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2005 | 29 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2007 | 197 | 0.060 |
Why?
|
| Immunologic Surveillance | 1 | 2005 | 22 | 0.060 |
Why?
|
| RNA Splicing Factors | 1 | 2025 | 7 | 0.060 |
Why?
|
| Ribonucleoproteins, Small Nucleolar | 1 | 2005 | 3 | 0.060 |
Why?
|
| SMN Complex Proteins | 1 | 2005 | 6 | 0.060 |
Why?
|
| Liver Diseases | 2 | 2021 | 160 | 0.060 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2005 | 7 | 0.060 |
Why?
|
| DNA | 3 | 2004 | 844 | 0.060 |
Why?
|
| Fatty Acids | 2 | 2019 | 202 | 0.060 |
Why?
|
| Aorta | 2 | 2021 | 110 | 0.060 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2025 | 26 | 0.060 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2004 | 9 | 0.060 |
Why?
|
| Th2 Cells | 1 | 2005 | 98 | 0.060 |
Why?
|
| Inflammation Mediators | 2 | 2003 | 178 | 0.060 |
Why?
|
| DNA Repair | 2 | 2017 | 250 | 0.060 |
Why?
|
| Cricetinae | 2 | 2002 | 368 | 0.060 |
Why?
|
| Eyelids | 1 | 2004 | 8 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 2 | 2017 | 180 | 0.060 |
Why?
|
| Spliceosomes | 1 | 2005 | 42 | 0.060 |
Why?
|
| Oligonucleotide Probes | 1 | 2004 | 42 | 0.060 |
Why?
|
| Tongue | 1 | 2004 | 16 | 0.060 |
Why?
|
| Receptor Cross-Talk | 1 | 2004 | 10 | 0.050 |
Why?
|
| Activin Receptors, Type I | 1 | 2004 | 15 | 0.050 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2004 | 28 | 0.050 |
Why?
|
| S Phase | 1 | 2004 | 79 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2004 | 57 | 0.050 |
Why?
|
| MAP Kinase Kinase Kinase 4 | 1 | 2004 | 1 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 386 | 0.050 |
Why?
|
| Homozygote | 1 | 2004 | 124 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 216 | 0.050 |
Why?
|
| Immune System | 1 | 2005 | 131 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 31 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2005 | 517 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2025 | 296 | 0.050 |
Why?
|
| Longevity | 1 | 2005 | 116 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2005 | 156 | 0.050 |
Why?
|
| Biopsy | 2 | 2021 | 449 | 0.050 |
Why?
|
| High Mobility Group Proteins | 1 | 2003 | 24 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 141 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 2 | 2016 | 43 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2005 | 526 | 0.050 |
Why?
|
| Immunoassay | 1 | 2004 | 71 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2005 | 279 | 0.050 |
Why?
|
| Munc18 Proteins | 1 | 2003 | 12 | 0.050 |
Why?
|
| PAX2 Transcription Factor | 1 | 2003 | 1 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2003 | 8 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2003 | 27 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2018 | 128 | 0.050 |
Why?
|
| Lens, Crystalline | 1 | 2003 | 16 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 1 | 2003 | 69 | 0.050 |
Why?
|
| Fatty Acid Synthases | 1 | 2023 | 24 | 0.050 |
Why?
|
| Hyperoxia | 1 | 2003 | 17 | 0.050 |
Why?
|
| Threonine | 1 | 2003 | 15 | 0.050 |
Why?
|
| Crosses, Genetic | 2 | 2017 | 110 | 0.050 |
Why?
|
| Wound Healing | 1 | 2004 | 192 | 0.050 |
Why?
|
| Receptors, Interferon | 2 | 2018 | 21 | 0.050 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2003 | 62 | 0.050 |
Why?
|
| Lung Injury | 1 | 2003 | 36 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 205 | 0.050 |
Why?
|
| RNA, Long Noncoding | 1 | 2025 | 170 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2014 | 16 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 2 | 2016 | 33 | 0.050 |
Why?
|
| MEF2 Transcription Factors | 1 | 2002 | 10 | 0.050 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2002 | 11 | 0.050 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2002 | 12 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2007 | 915 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2003 | 117 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 34 | 0.050 |
Why?
|
| Arthritis, Infectious | 1 | 2002 | 20 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2017 | 23 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2005 | 406 | 0.050 |
Why?
|
| Hedgehog Proteins | 1 | 2003 | 116 | 0.050 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 240 | 0.050 |
Why?
|
| Carbon Tetrachloride | 2 | 2015 | 11 | 0.050 |
Why?
|
| Sex Factors | 1 | 2025 | 980 | 0.050 |
Why?
|
| Parkinson Disease | 1 | 2004 | 134 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2004 | 291 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2002 | 49 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2017 | 63 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 68 | 0.050 |
Why?
|
| Weight Gain | 1 | 2023 | 168 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 153 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2002 | 52 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 541 | 0.050 |
Why?
|
| Sildenafil Citrate | 1 | 2021 | 14 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2002 | 102 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 183 | 0.040 |
Why?
|
| Vascular Stiffness | 1 | 2021 | 16 | 0.040 |
Why?
|
| Biomarkers | 3 | 2015 | 1431 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2003 | 348 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2002 | 260 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2022 | 124 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2021 | 48 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2003 | 183 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2021 | 68 | 0.040 |
Why?
|
| Viruses | 1 | 2002 | 81 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2021 | 61 | 0.040 |
Why?
|
| Gene Knockout Techniques | 2 | 2011 | 96 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2021 | 25 | 0.040 |
Why?
|
| Keratinocytes | 2 | 2013 | 65 | 0.040 |
Why?
|
| Lyme Disease | 1 | 2002 | 122 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 165 | 0.040 |
Why?
|
| Neutropenia | 1 | 2020 | 69 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2005 | 430 | 0.040 |
Why?
|
| Bleomycin | 1 | 2020 | 34 | 0.040 |
Why?
|
| Mitochondria, Liver | 1 | 2019 | 13 | 0.040 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2019 | 9 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 49 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 110 | 0.040 |
Why?
|
| Necrosis | 1 | 2019 | 146 | 0.040 |
Why?
|
| Arenaviridae Infections | 1 | 2019 | 15 | 0.040 |
Why?
|
| Class III Phosphatidylinositol 3-Kinases | 1 | 2018 | 5 | 0.040 |
Why?
|
| U937 Cells | 1 | 2018 | 10 | 0.040 |
Why?
|
| Middle Aged | 4 | 2019 | 17921 | 0.040 |
Why?
|
| Scientific Experimental Error | 1 | 2018 | 1 | 0.040 |
Why?
|
| Retraction of Publication as Topic | 1 | 2018 | 1 | 0.040 |
Why?
|
| Cardiac Output | 1 | 2018 | 28 | 0.040 |
Why?
|
| Scientific Misconduct | 1 | 2018 | 12 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2018 | 30 | 0.040 |
Why?
|
| Face | 2 | 2011 | 36 | 0.040 |
Why?
|
| Multigene Family | 1 | 2018 | 102 | 0.040 |
Why?
|
| Skin Transplantation | 1 | 2019 | 154 | 0.040 |
Why?
|
| Amides | 1 | 2018 | 56 | 0.040 |
Why?
|
| Conditioning, Classical | 1 | 2018 | 7 | 0.040 |
Why?
|
| Physical Endurance | 1 | 2018 | 48 | 0.040 |
Why?
|
| Integrases | 1 | 2018 | 38 | 0.040 |
Why?
|
| Anisomycin | 2 | 2010 | 6 | 0.030 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 10 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 43 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2005 | 685 | 0.030 |
Why?
|
| Muscle Development | 1 | 2018 | 56 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2018 | 37 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2013 | 375 | 0.030 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2017 | 10 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2018 | 123 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2017 | 23 | 0.030 |
Why?
|
| Butylated Hydroxyanisole | 1 | 2017 | 2 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 68 | 0.030 |
Why?
|
| Proteomics | 1 | 2019 | 294 | 0.030 |
Why?
|
| Anaerobiosis | 1 | 2017 | 16 | 0.030 |
Why?
|
| Hepatectomy | 1 | 2017 | 64 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 387 | 0.030 |
Why?
|
| Genotype | 2 | 2010 | 668 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 57 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 859 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2008 | 136 | 0.030 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2016 | 16 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 930 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2017 | 99 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 73 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 161 | 0.030 |
Why?
|
| Hypertension | 1 | 2021 | 593 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 162 | 0.030 |
Why?
|
| Intestinal Mucosa | 2 | 2008 | 243 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 375 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 417 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 102 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2015 | 19 | 0.030 |
Why?
|
| Synaptosomes | 1 | 2015 | 16 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 36 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 263 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 4781 | 0.030 |
Why?
|
| Kainic Acid | 2 | 2005 | 8 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2005 | 192 | 0.030 |
Why?
|
| Amelogenin | 1 | 2014 | 2 | 0.030 |
Why?
|
| Protein Subunits | 2 | 2008 | 166 | 0.030 |
Why?
|
| p21-Activated Kinases | 1 | 2014 | 6 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 2015 | 42 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 1020 | 0.030 |
Why?
|
| Exocytosis | 1 | 2015 | 59 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 1 | 2015 | 31 | 0.030 |
Why?
|
| Armadillo Domain Proteins | 1 | 2015 | 27 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 36 | 0.030 |
Why?
|
| Imidazoles | 2 | 2006 | 84 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 48 | 0.030 |
Why?
|
| Lipolysis | 1 | 2015 | 47 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 297 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2014 | 59 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2014 | 34 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 458 | 0.030 |
Why?
|
| Integrin beta4 | 1 | 2014 | 35 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 79 | 0.030 |
Why?
|
| Bucladesine | 1 | 2014 | 6 | 0.030 |
Why?
|
| Adipose Tissue, White | 1 | 2015 | 87 | 0.030 |
Why?
|
| Oxidants | 1 | 2014 | 19 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2014 | 5 | 0.030 |
Why?
|
| Acinar Cells | 1 | 2014 | 8 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 86 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 6305 | 0.030 |
Why?
|
| Genome, Human | 1 | 2016 | 240 | 0.030 |
Why?
|
| Cell Transdifferentiation | 1 | 2013 | 15 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 391 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 206 | 0.030 |
Why?
|
| Regeneration | 1 | 2014 | 101 | 0.030 |
Why?
|
| Risk Factors | 2 | 2017 | 5341 | 0.030 |
Why?
|
| Progesterone | 1 | 2014 | 163 | 0.020 |
Why?
|
| Heme Oxygenase (Decyclizing) | 2 | 2003 | 9 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2013 | 140 | 0.020 |
Why?
|
| United States | 2 | 2016 | 7923 | 0.020 |
Why?
|
| Dependovirus | 1 | 2020 | 721 | 0.020 |
Why?
|
| Epidermis | 1 | 2013 | 37 | 0.020 |
Why?
|
| Cytosol | 2 | 2005 | 181 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 298 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2019 | 697 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 12 | 1 | 2012 | 1 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 13 | 1 | 2012 | 1 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2014 | 185 | 0.020 |
Why?
|
| Receptors, Pituitary Hormone | 1 | 2012 | 1 | 0.020 |
Why?
|
| Brain Injuries | 2 | 2005 | 142 | 0.020 |
Why?
|
| Vagus Nerve | 1 | 2012 | 21 | 0.020 |
Why?
|
| Internet | 1 | 2016 | 467 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 147 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1131 | 0.020 |
Why?
|
| Bacterial Proteins | 2 | 2008 | 775 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 237 | 0.020 |
Why?
|
| Vitamin A | 1 | 2012 | 28 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2012 | 98 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2012 | 68 | 0.020 |
Why?
|
| Genitalia, Male | 1 | 2011 | 10 | 0.020 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2011 | 17 | 0.020 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2011 | 13 | 0.020 |
Why?
|
| Oxygen | 2 | 2003 | 321 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 191 | 0.020 |
Why?
|
| Cell Communication | 1 | 2012 | 132 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2002 | 112 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 245 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2011 | 129 | 0.020 |
Why?
|
| Superoxides | 1 | 2011 | 72 | 0.020 |
Why?
|
| Amnesia | 1 | 2010 | 9 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 14662 | 0.020 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2010 | 5 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 66 | 0.020 |
Why?
|
| Spleen | 2 | 2002 | 483 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2011 | 113 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2010 | 35 | 0.020 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2010 | 10 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 147 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2010 | 27 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 94 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 351 | 0.020 |
Why?
|
| Platelet Function Tests | 1 | 2010 | 11 | 0.020 |
Why?
|
| Cell Surface Extensions | 1 | 2010 | 6 | 0.020 |
Why?
|
| Platelet Count | 1 | 2010 | 26 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 608 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2010 | 24 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 302 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2010 | 39 | 0.020 |
Why?
|
| Adult | 2 | 2018 | 17134 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 2019 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5528 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 70 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2008 | 133 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2011 | 220 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2008 | 130 | 0.020 |
Why?
|
| Action Potentials | 1 | 2008 | 111 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2008 | 77 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2007 | 23 | 0.020 |
Why?
|
| Antigens, CD1d | 1 | 2007 | 29 | 0.020 |
Why?
|
| Artifacts | 1 | 2008 | 127 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2370 | 0.020 |
Why?
|
| Antigens, CD1 | 1 | 2007 | 41 | 0.020 |
Why?
|
| Serpin E2 | 1 | 2007 | 3 | 0.020 |
Why?
|
| Deubiquitinating Enzyme CYLD | 1 | 2007 | 5 | 0.020 |
Why?
|
| Streptolysins | 1 | 2007 | 10 | 0.020 |
Why?
|
| Guanosine Diphosphate | 1 | 2007 | 19 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2007 | 22 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 509 | 0.020 |
Why?
|
| Serpins | 1 | 2007 | 19 | 0.020 |
Why?
|
| Pneumococcal Infections | 1 | 2007 | 38 | 0.020 |
Why?
|
| Streptococcus pneumoniae | 1 | 2007 | 66 | 0.020 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2007 | 30 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 375 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2007 | 31 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2008 | 193 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 2007 | 26 | 0.020 |
Why?
|
| Antibodies | 1 | 2008 | 186 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2007 | 64 | 0.020 |
Why?
|
| Dishevelled Proteins | 1 | 2006 | 6 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 870 | 0.020 |
Why?
|
| Fibrosis | 1 | 2007 | 162 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 13 | 0.020 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2006 | 9 | 0.020 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2006 | 13 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 14 | 0.020 |
Why?
|
| Myelin Proteins | 1 | 2006 | 30 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 529 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 52 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2007 | 219 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 127 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 149 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 299 | 0.020 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2006 | 72 | 0.010 |
Why?
|
| T-Box Domain Proteins | 1 | 2005 | 38 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2006 | 103 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 2006 | 132 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2005 | 9 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2005 | 54 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 221 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 2005 | 29 | 0.010 |
Why?
|
| DNA, Helminth | 1 | 2005 | 9 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 32 | 0.010 |
Why?
|
| Thiazoles | 1 | 2005 | 47 | 0.010 |
Why?
|
| Methacrylates | 1 | 2005 | 40 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2005 | 147 | 0.010 |
Why?
|
| Medial Forebrain Bundle | 1 | 2005 | 3 | 0.010 |
Why?
|
| Oxidopamine | 1 | 2005 | 6 | 0.010 |
Why?
|
| Autonomic Denervation | 1 | 2005 | 2 | 0.010 |
Why?
|
| Facial Nerve Diseases | 1 | 2005 | 3 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 34 | 0.010 |
Why?
|
| Genes, Helminth | 1 | 2005 | 57 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2007 | 324 | 0.010 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2004 | 19 | 0.010 |
Why?
|
| Phosphoserine | 1 | 2004 | 10 | 0.010 |
Why?
|
| Axotomy | 1 | 2004 | 8 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2005 | 35 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 2004 | 26 | 0.010 |
Why?
|
| Cell Count | 1 | 2005 | 134 | 0.010 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2004 | 8 | 0.010 |
Why?
|
| Sciatic Nerve | 1 | 2004 | 29 | 0.010 |
Why?
|
| Phosphopeptides | 1 | 2004 | 9 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 66 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2006 | 330 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 110 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2005 | 138 | 0.010 |
Why?
|
| STAT4 Transcription Factor | 1 | 2004 | 8 | 0.010 |
Why?
|
| Biological Transport | 1 | 2005 | 291 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 302 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2005 | 126 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 398 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2003 | 3 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2003 | 11 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 329 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2003 | 28 | 0.010 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2005 | 87 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 78 | 0.010 |
Why?
|
| G1 Phase | 1 | 2003 | 57 | 0.010 |
Why?
|
| Heme Oxygenase-1 | 1 | 2003 | 20 | 0.010 |
Why?
|
| Protein Folding | 1 | 2005 | 268 | 0.010 |
Why?
|
| Mothers | 1 | 2006 | 276 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2003 | 44 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2003 | 32 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2003 | 42 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2003 | 22 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2002 | 27 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 2002 | 10 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2002 | 30 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2005 | 234 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 52 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2002 | 39 | 0.010 |
Why?
|
| Ionophores | 1 | 2002 | 11 | 0.010 |
Why?
|
| Peroxidase | 1 | 2003 | 70 | 0.010 |
Why?
|
| Myoblasts | 1 | 2003 | 64 | 0.010 |
Why?
|
| Ionomycin | 1 | 2002 | 16 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2002 | 50 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 77 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 2002 | 20 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2004 | 417 | 0.010 |
Why?
|
| Camptothecin | 1 | 2002 | 29 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2003 | 348 | 0.010 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2002 | 25 | 0.010 |
Why?
|
| Phagocytes | 1 | 2002 | 52 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 2002 | 38 | 0.010 |
Why?
|
| Motor Activity | 1 | 2005 | 346 | 0.010 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2001 | 16 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 365 | 0.010 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2002 | 71 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2002 | 174 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 149 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2002 | 261 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2001 | 127 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 2002 | 200 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2002 | 229 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2002 | 248 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 495 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 449 | 0.010 |
Why?
|
| Influenza A virus | 1 | 2002 | 124 | 0.010 |
Why?
|
| Age Factors | 1 | 2004 | 1570 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 727 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2008 | 5696 | 0.010 |
Why?
|